Cementless Total Knee Arthroplasty (TKA) Market is to grow by USD 2.40 billion from 2022 to 2027, Aesculap Implants Systems LLC and Allegra Orthopaedics Ltd. are among the key companies -Technavio

2024-02-07
NEW YORK, Feb. 6, 2024 /PRNewswire/ -- The
cementless total knee arthroplasty (TKA) market is estimated to grow by
USD 2.40 billion from 2022 to 2027 at a
CAGR of 22.15% according to Technavio. The market is segmented by product (fixed-bearing and mobile-bearing), end-user (hospitals, orthopedic clinics, and ambulatory surgical centers), and geography (North America, Europe, Asia, and Rest of World (ROW)). Aesculap Implants Systems LLC, Allegra Orthopaedics Ltd., B. Braun SE, Beijing Chunlizhengda Medical Instruments Co. Ltd., C2F Implants, Conformis Inc., Corin Group Plc, DJO Global Inc., Euromed Implants GmbH, Exactech Inc., GROUP FH ORTHO, Johnson and Johnson, Medacta Group SA, MicroPort Scientific Corp., Smith and Nephew plc, Stryker Corp., Symbios Orthopedie SA, United Orthopedic Corp., Waldemar Link GmbH and Co. KG, and Zimmer Biomet Holdings Inc. are key companies.
Continue Reading
Cementless Total Knee Arthroplasty (TKA) Market is to grow by USD 2.40 billion from 2022 to 2027, Aesculap Implants Systems LLC and Allegra Orthopaedics Ltd. are among the key companies -Technavio
Preview
来源: PRNewswire
Technavio has announced its latest market research report titled Global Cementless Total Knee Arthroplasty (TKA) Market 2023-2027
To understand more about the information services market, request a Free sample report
B. Braun SE - The company offers cementless total knee arthroplasty with the latest developments and technology in the hospital care segment. The company offers products and services for patients, especially for infusion therapy, nutrition therapy, and pain therapy. Its products include infusion and nutrition solutions, as well as specific medications.
The rise in the number of sports injuries is notably driving market growth. The prevalence of arthritis in the US is expected to rise, with adults diagnosed projected to increase from 54.4 million (2013-2015) to 78.4 million in 2020, as reported by the CDC. Symptomatic knee osteoarthritis affects about 10% of men and 13% of women aged over 60, according to the NIH. This aging population and growing orthopedic issues, including arthritis, contribute to the rising demand for knee replacement surgeries, particularly for cementless total knee arthroplasty (TKA).
Increasing demand for 3D-printed knee implants is the key trend.
The high cost of cementless TKA is the major challenge impeding growth.
Drivers, Trends, and Challenges have an impact on market dynamics and can impact businesses. Find some insights from a free sample report!
Why Buy?
Add credibility to strategy
Analyzes competitor's offerings
Get a holistic view of the market
Grow your profit margin with Technavio- Buy the Report
Cementless Total Knee Arthroplasty (TKA): Benefits
Cementless total knee arthroplasty (TKA) presents numerous advantages within orthopedic surgery, particularly in the realm of knee replacement procedures. This method eliminates the reliance on cement for securing implant components to the bone, opting instead for advanced designs and materials to ensure stability and fixation. Key technologies associated with cementless TKA encompass orthopedic surgery, knee replacement, joint replacement surgery, knee arthroplasty, orthopedic implants, innovations in knee surgery, medical devices, surgical procedures, arthritis treatment, and bone health. Additionally, these encompass implantable medical devices, advancements in healthcare technology, promotion of knee joint health, solutions addressing osteoarthritis, innovations in orthopedics, advancements in medicine, the market for knee implants, surgical implant technology, and overall improvement in musculoskeletal well-being.
What are the key data covered in this Cementless Total Knee Arthroplasty (TKA) Market Report?
CAGR during the forecast period
Detailed information on factors that will drive the growth between 2023 and 2027
Precise estimation of the size and its contribution to the parent market
Accurate predictions about upcoming trends and changes in consumer behavior
Growth of the Cementless Total Knee Arthroplasty (TKA) industry across North America, Europe, Asia, and Rest of the World (ROW)
A thorough analysis of the competitive landscape and detailed information about vendors
Comprehensive analysis of factors that will challenge the growth of Cementless Total Knee Arthroplasty (TKA) vendors
Technavio's SUBSCRIPTION platform
Related Reports
The
orthopedic surgical robots market size is estimated to grow by USD 808.5 million at a CAGR of 20.11% between 2022 and 2027.
The
Global Bone Replacement Market size is estimated to grow by USD 5,611.29 million at a CAGR of 6.88% between 2022 and 2027.
ToC:
Executive Summary
Market Landscape
Market Sizing
Historic Sizes
Five Forces Analysis
Segmentation by Product
Segmentation by End-user
Segmentation by Geography
Customer Landscape
Geographic Landscape
Drivers, Challenges, & Trends
Company Landscape
Company Analysis
Appendix
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging trends and provide actionable insights to help businesses identify opportunities and develop effective strategies to optimize their positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable insights to identify opportunities in existing and potential areas and assess their competitive positions within changing scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com
SOURCE Technavio
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。